Welcome to your Daily Dose of Health Tech Innovation!
Stay ahead with the latest breakthroughs revolutionizing healthcare—from AI diagnostics to remote care solutions.
We bring you expert-curated insights, emerging trends, and must-know updates from the digital health frontier.
Whether you’re a clinician, innovator, or health tech enthusiast, this roundup delivers what matters most.
Let’s dive into the future of health, one innovation at a time.
BioLineRx and Hemispherian AS Form JV to Develop GLIX1 for Cancer
BioLineRx Ltd., a clinical-stage biopharmaceutical company that specializes in oncology and rare diseases, has joined forces with Hemispherian AS, a Norwegian biotech firm that focuses on small molecule cancer treatments, to form a joint venture. The goal is to develop GLIX1, an innovative oral small molecule designed to target the DNA damage response in glioblastoma and other types of cancer. GLIX1 works by activating TET2 in cancer cells, which causes breaks in the DNA and triggers programmed cell death, specifically in malignant cells.
OMRON Healthcare Surpasses 400 Million Blood Pressure Monitor Sales
OMRON HEALTHCARE Co., a top global leader in medical devices focused on preventive healthcare, has shared that it has sold more than 400 million blood pressure monitors around the world. This achievement shows the company’s ongoing commitment to enhancing health outcomes by making home blood pressure monitoring and preventive cardiovascular care more accessible and effective. OMRON first launched its own branded blood pressure monitor in 1973, a time when blood pressure checks were only possible in medical offices. Thanks to technological advancements, people can now easily and accurately check their blood pressure at home. OMRON Healthcare keeps pushing for innovation to better manage blood pressure and help identify serious conditions like atrial fibrillation early on.
Leo Cancer Care Launches Grace Upright Photon Therapy System
Leo Cancer Care is introducing Grace at ASTRO 2025, a new upright photon therapy system that promises to change how radiation treatment is done. Named after Grace Hopper, a groundbreaking computer scientist and U.S. Navy Rear Admiral, the name highlights the company’s drive to move away from old ways in cancer care. Unlike standard radiation therapy, where patients lie flat, Grace allows patients to be treated while standing upright. New global studies suggest that this position can lead to more stable and consistent placement of organs during treatment. Patients who have used Grace say they feel more comfortable and more involved during their sessions.
Vyome Holdings Acquires MIT AI Spinout Oculo Health
Vyome Holdings, Inc, a clinical-stage healthcare holding company, announced it has acquired substantially all of the assets of Oculo, Inc., an AI startup launched at the Massachusetts Institute of Technology. Concurrent with this transaction, Vyome has launched a new business unit focused on using AI to tackle inflammation. This new business unit will leverage Oculo’s assets to develop an AI psychiatrist trained on data from both the US and India, and will be overseen by a newly-formed Vyome Board of Directors AI subcommittee comprised of Krishna Gupta, Mohanjit Jolly, and Stash Pomichter – all of whom are MIT alumni with deep AI expertise.
medAstra Launches Space-Grade Medical Systems for Earth Use
medAstra, a new company starting from the nonprofit BioAstra, has officially begun operations with a goal to bring the same high level of reliability seen in space medicine into everyday healthcare. The company first created adherence kits to help astronauts during space missions. Now, these specially designed kits are being used in three fast-growing areas where accuracy is crucial and mistakes can have serious outcomes: post-surgical care, commercial space travel, and advanced longevity medicine.
To share your insights, please write to us at sudipto@intentamplify.com
